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Abstract
Introduction—The ability to better prognosticate burn injury outcome is challenging and 
historically, most center use the Baux or revised Baux score to help prognosticate burn outcome, 
however, the weighted contribution of comorbidity on burn mortality has traditionally not been 
accounted for nor adequately studied. We therefore sought to determine the effect of 
comorbidities, using the Charlson comorbidity index (CCI) on burn mortality.
Methods—The purpose of this study was to determine the effect of comorbidities on burn injury 
mortality as determined by the LA50 (lethal TBSA burn at which 50% of the cohort will succumb 
from the burn injury) in a retrospective analysis of patients admitted to a regional burn center from 
2002–2012. Independent variables analyzed included basic demographics, burn mechanism, 
presence of inhalation injury, TBSA (total body surface area), length of hospital stay, and pre-
existing comorbidities. Bivariate analysis was performed and logistic regression modeling using 
significant variables was utilized to estimate odds of death.
Results—7640 patients were included in this study. Overall survival rate was 96%. 40% of our 
burn cohort had at least one comorbidity. There was a linear increase in the likelihood of death 
with an increase in CCI. The logistic regression model for mortality outcomes identified four 
statistically significant variables: age, TBSA, inhalational injury and the presence of comorbidities 
(OR = 1.59 for each 1 point increase in CCI; 95% CI 1.44–1.77). The unadjusted LA50 was 53% 
for the entire cohort. Partial adjustment multivariate regression controlling for burn mechanism 
and inhalation injury only, produced a slight reduction in LA50 for the 0–18 and 19–64 age 
categories to 76% and 48%, respectively, but a significant decrease occurred in the ≥ 65 years age 
group with a reduced LA50 to 20% (p<0.001). After full adjustment for all significant covariates, 
including comorbidities, the independent magnitude of effect of comorbidities on the LA50 was 
evident in the <65 cohort. The full adjustment showed a LA50 decreased by 15 and 5%, 
respectively in the 0–18 and >18–65 age groups respectively (p<0.001), however, in the >65 years 
age cohort there was no change in the LA50.
Conclusion—Preexisting comorbidities have a significant effect on burn injury mortality in all 
age groups, particularly the younger burn population. The measured effect of comorbidities in the 
>65yr age cohort was mitigated by the co-linearity between age and comorbidities. The inclusion 
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of CCI is imperative so as to better prognosticate burn outcome and help guide expectations and 
resource utilization, particularly in the younger burn cohort..
Introduction
Burn injuries are among the most devastating of all injuries and a major global public health 
crisis.[1,2] Burns are the fourth most common type of trauma worldwide, following traffic 
accidents, falls, and interpersonal violence.[3] Survival following burn injury has increased 
in the United States over the past 50 years. This can be attributed the advances in our 
understanding of burn injury, early nutrition, improved critical care, infection control and 
early excision and grafting of burn wounds within a multidisciplinary burn care team model.
Objective estimates of the probability of death from burn injuries are difficult. The most 
widely used formulas for the prediction of mortality from burns are based on a minimal set 
of easily obtained variables. A classic example based on the Baux Score[4,5] calculated the 
percent likelihood of mortality as the patient’s age in years plus the percentage of the total 
body-surface area (TBSA) that was burned. This formula has become obsolete.[6] The 
ability to better prognosticate burn outcome is challenging and most burn centers use the 
Baux score or its revision (probability of mortality = Age + Percent TBSA + Presence of 
Inhalation Injury), to help prognosticate of burn injury outcome upon presentation, but the 
weighted contribution of comorbidity on burn mortality has not been adequately studied.
In 1987, Charlson et al. developed the Charlson comorbidity Index (CCI) to predict the ten-
year mortality of patients with a range of medical conditions.[7] Each condition is given a 
score from one to six. A higher score predicted the increased likelihood of mortality. Older 
adults also tend to be at increased risk for other adverse outcomes including longer lengths 
of stay and higher hospital costs following burn injury as compared with younger patients 
with similar injuries.[8] There are several potential reasons for worse burn outcome in older 
adults. Preexisting medical problems—including cardiovascular, pulmonary, and renal 
disease—can complicate fluid resuscitation, a cornerstone of the early post-burn 
management period. Surgical management can also be more complicated in older patients 
because blood loss, intubation, and anesthesia may be poorly tolerated.[9] However, the 
relative impact of pre-existing medical comorbidities on survival following burn injury 
remains poorly understood.
Given the increasing number of older adults in the population and their persistent injury risk 
factors, there will likely be a greater number of older adults sustaining burn injury. We 
therefore sought to examine the impact of pre-existing medical co-morbidities on in-hospital 
mortality. The primary objective of the study was to determine the measured effect 
comorbidities, using the updated Charlson comorbidity index, on burn injury mortality based 
on LA50 (lethal TBSA burn at which 50% of the cohort will succumb from the burn injury). 
We hypothesize that preexisting comorbidities will have a significantly measureable effect 
on burn injury mortality.
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Methods
This is a retrospective study of all burn patients admitted to the University of North Carolina 
Jaycee Burn Center from 2001 to 2012. This study was conducted following approval from 
our Institutional Review Board. The North Carolina Jaycee Burn Center at UNC was 
established in 1981 and averages more than 1200 acute admissions per year. The burn center 
is a single unit, 36-bed facility that has been verified by the American Burn Association for 
pediatric and adult care.
The medical records of subjects identified by the UNC Burn database query were reviewed 
to verify baseline demographic data, injury characteristics, and provide detailed information 
on medical comorbidities. Injury characteristics of interest included burn etiology, TBSA 
burned, presence of inhalation injury, and intubation status on admission to the burn center. 
Inhalation injury diagnosis was based on history, physical examination, and/or 
bronchoscopic examination.
To examine the effect of baseline medical comorbidities on outcome, a modified Charlson 
Comorbidity Index score was calculated for each patient. The standardized Charlson Index 
has been reported to accurately predict the probability of mortality within 1 year for a 
number of medical conditions. [7,10] The score is the weighted sum of comorbid conditions. 
There are 17 comorbid conditions included in the score and each is assigned a weight from 1 
to 6 points. The weighted sum of all comorbid conditions is the patient’s Charlson score. 
(Table 1)
The outcomes of interest in this study included in-hospital mortality. Baseline patient and 
injury characteristics were compared between groups (Lived/Died) using Analysis of 
Variance for continuous variables and chi-squared for discrete variables. We employed both 
univariate and multivariate models in order to determine the relative influence of 
comorbidities when controlling for other variables. To determine LA 50 TBSA, we used a 
multivariate logistic regression model controlling for pertinent confounders (age, inhalation 
injury, mechanism of injury and comorbidities). We categorized our burn cohort into 3 age 
groups (0–18, 19–64, and ≥65) and determined the LA50 for each patient population. We 
used linear regression to examine hospital length of stay and logistic regression to examine 
mortality. A comparison of Area Under the Receiver Operating Characteristic (AUROC) 
curve between regression models was done with and without CCI to determine accuracy of 
including CCI in predicting burn mortality. Assessment of co-linearity between variables in 
the logistic regression model was performed using the Variance Inflation Factor (VIF) 
Stata/MP (Version 12) (Statacorp, College Station, TX) was used for all data management 
and statistical analysis.
Results
A total of 7,640 patients were admitted and treated during the study period with a mean age 
of 32 ± 22 years. Of these patients, 68% were males. The age category cohort of 0–18, 19–
64, and ≥65 years accounted for 30%, 62% and 8%, respectively. Caucasians made up 51% 
of the population. The most common mechanism of burn injury was scald (49%) followed 
Knowlin et al. Page 3
Burns. Author manuscript; available in PMC 2017 January 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
by flame injury (45%). The overall mean TBSA for this population was 8.6± 12%. (Table 2) 
There was no significant difference in TBSA based on race or sex but a difference in noted 
within the age categories. The mean %TBSA for each age the category cohort of 0–18, 19–
64, and ≥65 years was 6.8 ± 7.7 %, 9 ± 13.1%, and 11.6 ± 15.3%, respectively (p < 0.001). 
The mean length of hospital and ICU stay was 12.7 ± 24.7 days and 5.1 ± 20.2 days 
respectively (p < 0.001). Burn patients with at least one comorbidity represented 40% of the 
population (n=3,057).
During the study period, the overall mortality was 4%. The mean age of survivors vs. non-
survivors was 31 ± 21.9 years and 58 ± 20.5 years, respectively. (Table 3) TBSA was 
significantly associated with mortality (p<0.001). The average TBSA for patients who died 
was 39.9 ± 29.2%. Although patients with an inhalation injury represented a small portion 
(7%) of the cohort, 23% of these patients in the burn cohort died. Patients who died 
presented to the hospital with an average of 2.6 ± 1.9 comorbidities. Flame burns were 
associated with significantly higher mortality rate (7%) than scald (1%) and other types of 
burns (4%, p<0.001). Race and gender had no significant impact on mortality.
A multivariate logistic regression was then performed on patient demographics and clinical 
characteristics in a model for mortality outcomes identifying five variables as statistically 
significant: age, TBSA, mechanism of injury, presence of inhalation injury (odds ratio [OR] 
= 2.85; 95% confidence interval [CI] 1.99–4.08), and presence of comorbidities. (Table 4) 
The patient groups older than 18 years of age, 19 to 64 (OR = 2.92; 95% CI 1.31–6.52) and 
older than 65 years old (OR = 8.32; 95% CI 3.347–20.793), had higher odds of mortality 
compared to their younger counterparts. The odds of mortality increased 1.59 times (95% 
confidence interval 1.44–1.77) for each point increase in CCI after controlling for patient 
demographics and burn characteristics. There is a linear increase in the likelihood of death 
with an increase in CCI. (Figure 1) Comparison of AUROC was done on logistic regression 
models with and without CCI to determine accuracy of this variable in predicting mortality. 
There was a significant difference between the two models (p< 0.01).
LA50 determination was based on a logistic regression of burn outcome by TBSA that 
increased by a geometric progression. (Table 5) The unadjusted LA50 for the entire study 
population was 53%. A partial adjustment for inhalation injury and mechanism of burn led 
to a reduction in LA50 of 8%. (Figures 2A & B). A multivariate logistic regression was then 
repeated using significant variables from the bivariate analysis, adjusting for age, 
mechanism of burn, presence of inhalation injury, and comorbidities. The unadjusted 
regression model for each age group showed a LA50 for age groups 0–18, 19–64, and ≥65 
years of 81%, 55%, and 30% TBSA, respectively. As expected, there was a decrease in 
LA50 for TBSA as mechanism of burn and inhalation injury were factored into the model. 
Partial adjustment multivariate regression controlling for burn mechanism and inhalation 
injury only, produced a slight reduction in LA50 for the 0–18 and 19–64 age categories to 
76% and 48%, respectively (Fig. 3A &4A), but a significant decrease occurred in the ≥ 65 
years age group with a reduced LA50 to 20% (p<0.001).(Fig 5A) After full adjustment for 
all significant covariates, including comorbidities, the independent magnitude of effect of 
comorbidities on the LA50 was evident in the <65 cohort. When compared to the partially 
adjusted model, the full adjustment showed LA50 decreased further from 76 to 61% and 48 
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to 43% TBSA, respectively in the 0–18 and >18–65 age groups respectively (p<0.001), 
however in the >65 years age group, there was no change in the LA50. (Fig 5B) These 
results suggest that the presence of documented pre-existing comorbidities has a significant 
effect on the predicted probability of mortality, particularly in burn patients ≤ 65 years. 
Investigation of co-linearity in the logistic regression model was performed using Variance 
Inflation Factor. Independent variables TBSA, Inhalation injury and mechanism of burn had 
VIF less than 4. Age and comorbidities each had a VIF of 21 and 146 respectively. An 
interaction term for produced a VIF of 193 and tolerance of 0.005
Discussion
In this study, we show the weighted contribution of the addition of comorbidities, using the 
CCI to the predictive probability of death following burn injury. Previous studies examining 
mortality from burns have identified three major risk factors associated with increased 
mortality: age > 60 years old, TBSA > 40%, and presence of inhalation injury.[11–13] 
Presence of all three risk factors is associated with mortality of 90%. [11,12] Smoke 
inhalation injury is generally considered to be the strongest predictor of burn mortality. [13] 
In our burn population, however, we found that the presence of preexisting medical 
comorbidities had significant impact on mortality as evident by significant reduction in 
LA50 in those aged ≤ 65 years. In addition, we found the measured effect of comorbidities 
to be most pronounced in patients ≤ 18, suggesting that younger patients with medical 
comorbidities are more susceptible to worse outcomes. In the ≥65 age group the fully 
adjusted model showed only a 1% TBSA decrease in LA50 from the partially adjusted 
model due to co-linearity between age and the presence of comorbidities. Co-linearity was 
confirmed with VIF greater than 10 and tolerance close to 0.
Outcomes in trauma patients have been known to be effected by fraility.*** Frailty has been 
defined in older adults as the increase vulnerability to stressors due to age-related 
physiologic declines across multiple organ systems and risk of adverse outcomes.** 
However, frailty isn’t related to just aging alone and can affect those that are chronically ill 
at younger ages.** There is no current gold standard for diagnosing frailty. There are many 
screening tools such as FRAIL (Fatigue, Resistance, Ambulation, Illness, Loss of Weight) 
and Frailty Index (FI), that can be utilized for early assessment and identification of 
vulnerable patients.*** Once assessment has been completed, physicians and family must 
weigh the risk and benefits of interventions as well as make decisions regarding 
aggressiveness of care.
Historically, several models have been created to help guide prognostication of burn 
outcome. The Baux score described in 1961 was used to predict mortality based on age and 
percent TBSA alone. [4]This model did not account for inhalation injury. The Abbreviated 
Burn Severity Index (ABSI) created in 1982 subsequently accounted for the presence of 
inhalation injury but excluded comorbidities. [14]Since 2007, other prediction models that 
have been utilized are the Belgian Outcome in Burn Injury (BOBI) model and revised Baux 
score to predict burn outcomes. However, these latest models do not take into account the 
effects preexisting medical conditions[15,16]and may result in overestimation or 
underestimation of burn severity.
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There are a few studies that examined the impact of comorbidities on burn injuries. 
However, those studies were done on a smaller population and didn’t adequately weigh the 
contribution of comorbidities on burn mortality. [17–22] A larger 2007 study was done by 
Thombs et al [23] looked at the effect of various comorbidities on burn injury mortality 
based on the National Burn Repository (NBR) report on 31,338 burn records from 1995–
2005. They found that various pre-existing medical conditions, using the Charlson 
Comorbidity index and Elixhauser method of comorbidity measurement, affected burn 
mortality. Medical conditions such as HIV/Aids, metastatic cancer, liver disease, and renal 
disease had a poor prognostic outcome in acute burn injury.
The limitations of this study are those inherent to any study with a retrospective. Though we 
have a great sample size, this is a single center study, which may affect generalizability of 
our findings. Utilizing a large administrative dataset with pertinent comorbidity data would 
help overcome this limitation or indeed a prospective multicenter study. Also, the 
contribution of frailty and its effect on to outcome was not evaluated. Furthermore, the 
Charlson comorbidity index was originally based on the predictive power to estimate 
mortality in medicine patients and was never intended to generalizations to surgical or burn 
cohort. It has undergone several modifications and has been utilized and validated in other 
surgical patient cohort.[23–29]
Conclusion
Patient mortality remains the primary outcome measure for burn care. Scoring systems aim 
to use the most predictive premorbid and injury factors to yield an expected likelihood of 
death for a given patient. Age, burn surface area and inhalational injury remain the 
mainstays of burn prognostication, but their fidelity is imprecise without accounting for pre-
existing comorbidity data. Our study has elucidated the measured effect of comorbidities on 
the LA 50 TBSA. With increasing health care cost, the inclusion of CCI is imperative to 
better prognosticate burn outcome and help guide expectations and resource utilization.
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Figure 1. 
The predicted probability for death based on Charlson co-morbidity index
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Figure 2. 
Unadjusted (A) and Adjusted (B) LA50 %TBSA for entire burn cohort
* Adjusted for Burn Mechanism, Age and Inhalational injury
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Table 1
Charlson Comorbidity Index score System
Comorbidity Score
Myocardial infarction 1
Congestive heart failure 1
Peripheral vascular disease 1
Cerebrovascular disease 1
Dementia 1
Chronic pulmonary disease 1
Rheumatologic disease 1
Peptic ulcer disease 1
Mild liver disease 1
Diabetes without chronic complications 1
Diabetes with chronic complications 2
Hemiplegia or paraplegia 2
Renal disease 2
Solid tumor 2
Leukema 2
Lymphoma 2
Moderate or severe liver disease 3
AIDS/HIV 6
Metastatic solid tumor 6
Maximum comorbidity score 37
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Table 2
Patient characteristics.
Patient characteristics (n=7,640) n Mean (± SD) or %
Sex
 Male 5,244 69%
 Female 2,396 31%
Age
 Overall 32.0 (± 22.4)
 0–18 years 2,298 30%
 19–64 years 4,744 62%
 ≥ 65 years 598 8%
Type of Burn
 Flame 3,426 45%
 Scald 3,678 49%
 Other 480 6%
Inhalation
 Inhalation injury 562 7%
 No inhalation injury 7,078 93%
Charlson Comorbidity Index (CCI)
 Overall mean 7,640 0.906864 (± 1.4)
40%
TBSA
 Overall mean 7,640 8.6 (± 12.0)
 By sex
  Male 5,244 9.0 (± 12.6)
  Female 2,396 7.7 (± 10.7)
 By age
  0–18 years 2,298 6.8 (± 7.7)
  19–64 years 4,744 9.0 (± 13.1)
  ≥ 65 years 598 11.6 (± 15.3)
Survival
 Overall 7,274 96%
 By sex
  Male 5,017 96%
  Female 2,257 94%
 By age
  0–18 years 2,272 99%
  19–64 years 4,444 95%
  ≥ 65 years 422 77%
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Patient characteristics (n=7,640) n Mean (± SD) or %
ICU stay
 Overall mean 5.1 (± 20.2)
Hospital stay
 Overall mean 12.7 (± 24.7)
TBSA=total burn surface area
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Table 3
Bivariate analysis of patient demographics and clinical characteristics
Live Dead p- Value (p)
Age 30.9 (± 21.9) 58.3 (± 20.5) < 0.001
TBSA 7.3 (± 8.7) 39.9 (± 29.2) < 0.001
Inhalation < 0.001
 Inhalation injury 77% 23%
 No inhalation injury 97% 3%
CCI < 0.001
 Mean 0.8 (± 1.4) 2.6 (± 1.9)
 0 98% 2%
 1+ 91% 9%
Race 0.005
 White (51%) 94% 4%
 Other (49%) 96% 4%
Sex 0.082
 Male (69%) 96% 4%
 Female (31%) 94% 4%
ICU stay 4.1 (± 15.8) 28.6 (± 47.2)
LOS 11.9 (± 22.9) 30.6 (± 47.6)
Mechanism < 0.001
 Flame (45%) 93% 7%
 Scald (48%) 99% 1%
 Other (6%) 96% 4%
TBSA= total body surface area
CCI=Charlson comorbidity Index
LOS= length of hospital Stay
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Table 4
Multivariate logistic regression model of mortality in burn cohort
Variable Adjusted odds ratio, 95% Confidence interval (CI) p-Value
TBSA 1.09 (1.08–1.10) < 0.001
Age
 0–18 years (reference group)
 19–64 years 2.92 (1.31–6.52) 0.009
 ≥ 65 years 8.34 (3.35–20.79) < 0.001
Inhalation injury 2.85 (1.99–4.08) < 0.001
Mechanism of injury
 Scald (reference group)
 Flame 1.60 (1.03–2.50) 0.037
 Other 2.99 (1.57–5.74) 0.001
Charlson Comorbidity index (CCI) 1.59 (1.441–1.77) < 0.001
TBSA= total body surface area
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Table 5
Effect of prognostic factors on LA50 %TBSAa
Unadjusted Partially Adjusted for inhalation injury and mechanism Fully Adjustedb
Overall LA50 %TBSA 53% 45% 35%
Age
 ≤ 18 years 81% 76% 61%
 19–64 years 55% 48% 43%
 ≥ 65 years 30% 20% 19%
a
Lethal TBSA burn at which 50% of the cohort will succumb from the burn injury.
bAdjusted for inhalation injury, burn mechanism, and preexisting comorbidities.
Burns. Author manuscript; available in PMC 2017 January 30.
